Oligometastatic Lung Cancer With Brain Spread, Surgery and Later Recurrence
This lung cancer diagnosis at a glance
- Stage at diagnosis
- Stage IV
- Subtype
- Adenocarcinoma
- Sex
- male
- Spread to
- brain
- Treatment
- radiation, immunotherapy, surgery and chemotherapy
- Outcome
- Care Ongoing
Treatment course, step by step
- His brain metastasis was treated with stereotactic radiation.
- He then received anti-PD-L1 therapy with an initial response before local lung progression.
- He underwent right lower lobectomy and mediastinal lymph-node dissection.
- After later mediastinal nodal and distant recurrence, he started platinum-based chemotherapy.
What happened, in summary
A 62-year-old man and former 70-pack-year smoker was diagnosed with oligometastatic non-small cell lung cancer with a brain metastasis. The brain lesion was treated with stereotactic radiation, followed by anti-PD-L1 immunotherapy. He initially responded, but the lung tumor later began growing again. PET imaging showed a growing right lower-lobe mass with high metabolic activity. He underwent right lower lobectomy and mediastinal lymph-node dissection. Pathology showed sarcomatoid carcinoma with an adenocarcinoma component and no involved lymph nodes. His postoperative course was complicated by a prolonged chest-tube air leak, and he was discharged on postoperative day 11. He initially remained off treatment after surgery. After 15 months, however, the cancer returned with mediastinal nodal and distant metastases. At 25 months after surgery, he was alive with disease and receiving platinum-based chemotherapy.
Where this story comes from
This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full
How we source and attribute stories Accuracy and limitations
Collections this story belongs to
- Stage 4 Lung Cancer 384 stories
- Chemotherapy for Stage 4 Lung Cancer 217 stories
- Chemotherapy for Lung Cancer 386 stories
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer